• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐万古霉素肠球菌

Vancomycin-resistant enterococci.

作者信息

Chiew Y F

机构信息

Department of Laboratory Medicine, National University Hospital, Singapore.

出版信息

Ann Acad Med Singap. 1997 Nov;26(6):808-14.

PMID:9522984
Abstract

Vancomycin-resistant enterococci (VRE) are gaining much attention in the West, chiefly because of the lack of available antimicrobial therapy for VRE infections as most VRE are also resistant to drugs previously used to treat such diseases (e.g. aminoglycosides and ampicillin), the possibility that the vancomycin-resistant genes present in VRE can be transferred to methicillin-resistant Staphylococcus aureus (MRSA), and increasing reports of VRE and the trend towards endemicity in North America. There are three case reports and a study showing stool carriage of more than 10% from Singapore. One of the case reports is notable as the VRE isolated from the urinary tract is community-acquired. In Europe, there is a strong association between the use of avoparcin (a glycopeptide) in animal feeds and the emergence of VRE. Clonal dissemination resulting in nosocomial transmission is also demonstrated. Prior vancomycin use is a risk factor for the subsequent development of VRE bacteraemia. The laboratory plays an important role, namely, a) detection of VRE, and b) determination of susceptibilities of antimicrobials whereby possible therapeutic options may be instituted when antimicrobial intervention is indicated. There is a need to evaluate existing infection control measures against VRE to prevent it from becoming endemic in Singapore as had happened in North America.

摘要

耐万古霉素肠球菌(VRE)在西方正备受关注,主要原因如下:对于VRE感染缺乏有效的抗菌治疗方法,因为大多数VRE对以前用于治疗此类疾病的药物(如氨基糖苷类和氨苄西林)也具有耐药性;VRE中存在的耐万古霉素基因有可能转移至耐甲氧西林金黄色葡萄球菌(MRSA);以及北美地区VRE报告病例不断增加且有呈地方流行之势。有三例病例报告以及一项研究表明,新加坡粪便携带率超过10%。其中一例病例报告值得注意,因为从泌尿道分离出的VRE是社区获得性的。在欧洲,动物饲料中使用阿伏帕星(一种糖肽)与VRE的出现之间存在密切关联。也证实了克隆传播导致医院内传播。先前使用万古霉素是随后发生VRE菌血症的一个危险因素。实验室发挥着重要作用,即:a)检测VRE;b)确定抗菌药物敏感性,以便在需要进行抗菌干预时能够制定可能的治疗方案。有必要评估现有的针对VRE的感染控制措施,以防止其在新加坡像在北美那样成为地方流行病。

相似文献

1
Vancomycin-resistant enterococci.耐万古霉素肠球菌
Ann Acad Med Singap. 1997 Nov;26(6):808-14.
2
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).预防万古霉素耐药性传播的建议。医院感染控制实践咨询委员会(HICPAC)的建议。
MMWR Recomm Rep. 1995 Sep 22;44(RR-12):1-13.
3
Vancomycin-resistant enterococci: consequences for therapy and infection control.耐万古霉素肠球菌:对治疗和感染控制的影响
Clin Microbiol Infect. 2005 Jul;11 Suppl 4:43-56. doi: 10.1111/j.1469-0691.2005.01164.x.
4
Treatment options for vancomycin-resistant enterococcal infections.耐万古霉素肠球菌感染的治疗选择。
Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002.
5
Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.医疗环境外的耐万古霉素肠球菌:患病率、来源及对公共卫生的影响
Emerg Infect Dis. 1997 Jul-Sep;3(3):311-7. doi: 10.3201/eid0303.970307.
6
Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection.社区中耐万古霉素肠球菌的流行病学以及农场动物与人类感染的相关性。
J Hosp Infect. 1997 Oct;37(2):89-101. doi: 10.1016/s0195-6701(97)90179-1.
7
Vancomycin-resistant enterococci: why are they here, and where do they come from?耐万古霉素肠球菌:它们为何存在于此,又源自何处?
Lancet Infect Dis. 2001 Dec;1(5):314-25. doi: 10.1016/S1473-3099(01)00145-1.
8
Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.中国耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌共同定植或感染患者的患病率调查:一项基于医院的研究。
Chin Med J (Engl). 2009 Jun 5;122(11):1283-8.
9
Vancomycin-resistant enterococci.耐万古霉素肠球菌
Pharmacotherapy. 1996 Sep-Oct;16(5):819-29.
10
Epidemiology and risk factors of methicillin-resistant and vancomycin-resistant infections in Zhejiang China from 2015 to 2017.2015 年至 2017 年中国浙江地区耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌感染的流行病学和危险因素。
Antimicrob Resist Infect Control. 2019 May 30;8:90. doi: 10.1186/s13756-019-0539-x. eCollection 2019.